Neha Shah
Publications by Year
Research Areas
Chronic Lymphocytic Leukemia Research, Chronic Myeloid Leukemia Treatments, Eosinophilic Disorders and Syndromes, COVID-19 and healthcare impacts, Complex Network Analysis Techniques
Most-Cited Works
- → The effects of remote work on collaboration among information workers(2021)679 cited
- → Potent, transient inhibition of BCR-ABL with dasatinib 100 mg daily achieves rapid and durable cytogenetic responses and high transformation-free survival rates in chronic phase chronic myeloid leukemia patients with resistance, suboptimal response or intolerance to imatinib(2010)242 cited
- → The Downfall of Extraverts and Rise of Neurotics: The Dynamic Process of Status Allocation in Task Groups(2012)176 cited
- → Phase II study of treatment of advanced ovarian cancer with folate-receptor-targeted therapeutic (vintafolide) and companion SPECT-based imaging agent (99mTc-etarfolatide)(2014)113 cited
- → The Cost of Status Enhancement: Performance Effects of Individuals' Status Mobility in Task Groups(2010)96 cited
- → Homophily: Measures and Meaning(2020)95 cited
- → Performance Benefits From Providing Assistance in Networks: Relationships That Generate Learning(2015)50 cited
- → Mental health amongst obstetrics and gynaecology doctors during the COVID-19 pandemic: Results of a UK-wide study(2020)45 cited
- → Examining the Overlap(2016)36 cited
- → Dasatinib 50 mg or 70 mg BID compared to 100 mg or 140 mg QD in patients with CML in chronic phase (CP) who are resistant or intolerant to imatinib: One-year results of CA180034(2007)33 cited